Home › Research › Long-term cohort studies
Contributions of the Framingham Heart Study to stroke and dementia epidemiologic research at 60 years
Wolf PA.. Archives of neurology, 2012-05-01
Topic: Risk, prevention and care in population studies
Plain-language summary
The Framingham Heart Study, the longest-running prospective epidemiologic study in history, was initiated in 1948 in response to the rising toll of coronary heart disease and hypertension. During the ensuing decades, the study of other diseases, notably stroke and dementia, was added. In 1971, 5124 offspring of the original cohort of 5209 men and women were added, and a third generation of 4095 men and women were added in 2002.
What this study adds
Evidence grade: Moderate
This is a narrative review. This paper reviews how the Framingham Heart Study has contributed to stroke and dementia epidemiologic research over 60 years, including relating midlife and late-life risk factors to later stroke, dementia, and cognitive decline. It is a descriptive review, so it cannot show that any specific treatment would prevent or cure dementia.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Wolf, P. A. (2012). Contributions of the Framingham Heart Study to stroke and dementia epidemiologic research at 60 years. Archives of neurology. https://doi.org/10.1001/archneurol.2011.977
Vancouver
Wolf PA. Contributions of the Framingham Heart Study to stroke and dementia epidemiologic research at 60 years. Archives of neurology. 2012. doi:10.1001/archneurol.2011.977. PMID: 22213410.
BibTeX
@article{wolf2012-22213410,
author = {Wolf, P. A.},
title = {{Contributions of the Framingham Heart Study to stroke and dementia epidemiologic research at 60 years}},
journal = {Archives of neurology},
year = {2012},
doi = {10.1001/archneurol.2011.977},
pmid = {22213410},
url = {https://doi.org/10.1001/archneurol.2011.977}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- During the ensuing decades, the study of other diseases, notably stroke and dementia, was added.
- In 1971, 5124 offspring of the original cohort of 5209 men and women were added, and a third generation of 4095 men and women were added in 2002.
- The 3-generation structure was used to relate a host of risk factors measured in mid and late life to the subsequent development of stroke, dementia, and cognitive decline.
- It has also facilitated studies of family occurrence of disease over generations particularly for genomic research.
Why it matters
This paper reviews how the Framingham Heart Study has contributed to stroke and dementia epidemiologic research over 60 years, including relating midlife and late-life risk factors to later stroke, dementia, and cognitive decline. It is a descriptive review, so it cannot show that any specific treatment would prevent or cure dementia.
Study details
- Evidence strengthModerate
How this study scored 43/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Archives of neurology) |
| Journal's citation record | 3 / 4 | Archives of Neurology: journal h-index 353 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2012 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 71 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 4.4 citations a year over 16 year(s) since 2012 |
| Impact for its field and year | 2 / 6 | Cited 2.7× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 5 other studies in this library |
| Still being cited | 2 / 4 | Cited 15 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Philip A. Wolf: h-index 149 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Boston University: institution h-index 1,456 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 22213410) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 43 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1001/archneurol.2011.977
- PubMed: 22213410
- Original source →
- Free full text: PubMed Central →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
5 studies in the alzhub library list this one in their references.
Related studies in Long-term cohort studies from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.